Quick Takeaways
- ARK Investment Management LLC filed SCHEDULE 13G/A for Adaptive Biotechnologies Corporation Common Stock (ADPT).
- Disclosed ownership: 4%.
- Date of event: 30 Apr 2025.
ARK Investment Management LLC - 30 Apr 2025 SCHEDULE 13G/A Report for Adaptive Biotechnologies Corporation Common Stock (ADPT)
- Filing Manager
- ARK Investment Management LLC
- Reporting Manager
- ARK Investment Management LLC
- Symbol
- ADPT
- Shares outstanding
- 152,075,414 shares
- Disclosed Ownership
- 6,067,809 shares
- Ownership
- 4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 May 2025, 11:42:47 UTC
- Date of event
- 30 Apr 2025
- Previous filing
- 14 May 2025
- Next filing
- 06 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARK Investment Management LLC disclosed 4% ownership in Adaptive Biotechnologies Corporation Common Stock (ADPT) on 30 Apr 2025."
What Changed
- Previous schedule filing date: 14 May 2025.
- Current filing was accepted on 07 May 2025, 11:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 4% | 6,067,809 | 6,067,809 | 0 | /s/ Kellen Carter | Kellen Carter, Chief Compliance Officer |